Vesoma emerged from stealth with 60+ staff, a first humanoid and a bet that robots should learn physical work from their own failures rather than from human demonstrations. An early look at the thesis, the team and the risks.
RWE has committed to a 400 MW / 1,100 MWh battery at its Moerdijk power station, dispatched under capacity-steering agreements with TenneT to relieve congestion in Noord-Brabant. The project marks a shift in grid-scale storage from merchant arbitrage to contracted grid services.
Enveda closed a $311 million Series E at a $2 billion valuation, double a year ago. Two of its AI-discovered medicines, for eczema and obesity, produced positive early data in 2026. The round tests whether nature's chemistry can beat synthetic design at the clinic.
Third Point led a $3.36 billion convertible note into Nscale, with Nvidia contributing $1 billion. The $103.4 billion contract book looks like validation until you count the tenants, trace how much revenue is actually active, and read the conversion terms.
Project-S emerged from stealth on 2 September 2026 with a multi-million-euro seed led by Uni.Fund II and backed by ESA incubator programmes and Bavarian grants. It is building space-based radar, AI analytics and collision-avoidance software for the debris crowding low Earth orbit.
A $900,000 USSOCOM prototype contract puts Tycho.AI's man-packable interceptor at the centre of a counter-drone market now splitting into expensive missiles and cheap attritable drones.
Noon Energy's reversible solid-oxide battery promises 100+ hours of storage, the duration AI data centers need to run on renewables alone. Meta reserved 100 GWh and Sabanci will co-develop up to 1 GW, but the first 25 MW project is years away and the efficiency numbers are private.
Parabilis listed on Nasdaq in June with the largest US biotech IPO of 2026, then kept building: a first-in-class β-catenin:TCF inhibitor, a $125M Regeneron partnership and $1.1B in cash. The 2027 Phase 3 desmoid readout will test the platform.